# TIPS or Anticoagulation in Portal Vein Thrombosis

> **NCT03422419** · PHASE3 · WITHDRAWN · sponsor: **Insel Gruppe AG, University Hospital Bern**

## Conditions studied

- Thrombosis Portal Vein

## Interventions

- **DRUG:** Heparin
- **DEVICE:** TIPS

## Key facts

- **NCT ID:** NCT03422419
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-08-01
- **Primary completion:** 2020-10-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of funding
- **Last updated:** 2018-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03422419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03422419, "TIPS or Anticoagulation in Portal Vein Thrombosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03422419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*